Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Rechercher des publications
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 451 du 5 juin 2020
Qualité de vie, soins de support (8)
Menée au Japon auprès de 237 patientes atteintes d’un cancer du sein, cette étude analyse les facteurs associés au risque de déficience des fonctions de l’épaule après un curage ganglionnaire axillaire
Risk factors of impairment of shoulder function after axillary dissection for breast cancer
Menée au Japon auprès de 237 patientes atteintes d’un cancer du sein, cette étude analyse les facteurs associés au risque de déficience des fonctions de l’épaule après un curage ganglionnaire axillaire
Risk factors of impairment of shoulder function after axillary dissection for breast cancer
Masato Kikuuchi, Yoshiteru Akezaki, Eiji Nakata (et al.)
Objectives : Postoperative shoulder joint dysfunction has been observed at a certain rate after breast cancer surgery with axillary lymph node dissection. The purposes of this study were to verify the feasibility and effects of home-based exercise using a DVD and clarify the target of intensive intervention with physiotherapy by identifying the factors that cause postoperative shoulder dysfunction. Methods : The study comprised 237 female patients who underwent breast cancer surgery with [...]
A partir d’une revue systématique de la littérature publiée jusqu’en décembre 2019 (12 études, 516 patients), cette méta-analyse évalue l’efficacité, pour améliorer la santé cardiorespiratoire chez des patients atteints d’un cancer ou ayant survécu à la maladie, d’un entraînement fractionné de haute intensité
High-intensity interval training improves cardiorespiratory fitness in cancer patients and survivors: A meta-analysis
A partir d’une revue systématique de la littérature publiée jusqu’en décembre 2019 (12 études, 516 patients), cette méta-analyse évalue l’efficacité, pour améliorer la santé cardiorespiratoire chez des patients atteints d’un cancer ou ayant survécu à la maladie, d’un entraînement fractionné de haute intensité
High-intensity interval training improves cardiorespiratory fitness in cancer patients and survivors: A meta-analysis
Matthew P. Wallen, Declan Hennessy, Stephen Brown (et al.)
Objective : The primary objective of this systematic review and meta?analysis was to compare the effects of high?intensity interval training (HIIT) versus moderate?intensity continuous training (MICT) and usual care (UC) on cardiorespiratory fitness (peak V?O2) in cancer patients and survivors. Secondary objectives were to compare the effects of HIIT versus MICT and UC on other cardiopulmonary exercise testing (CPET) indices. Safety and adherence to HIIT were also evaluated. Methods : A [...]
Menée en Allemagne par questionnaire auprès de 181 patients atteints d’un cancer, cette étude transversale analyse leurs préférences et leur motivation concernant la pratique d’une activité physique
Motivation and preferences of cancer patients to perform physical training
Menée en Allemagne par questionnaire auprès de 181 patients atteints d’un cancer, cette étude transversale analyse leurs préférences et leur motivation concernant la pratique d’une activité physique
Motivation and preferences of cancer patients to perform physical training
Sabine Felser, Martin Behrens, Hans Lampe, Larissa Henze (et al.)
Objective : The aims of this cross?sectional study were to investigate the knowledge about and experience with exercise as well as the motivation and preferences (e.g. availability) of cancer patients to participate in training groups. Methods : From 11/2017?06/2018, 181 cancer patients undergoing or completing treatment responded to a compiled questionnaire. The stage of motivation (transtheoretical model of behavioural change), exercise?related knowledge, experience and preferences were [...]
Mené au Royaume-Uni sur 131 patients ayant survécu à un myélome multiple, cet essai de phase II évalue l’efficacité d’un programme d’exercices physiques pendant 6 mois pour réduire la fatigue et améliorer la force musculaire et la santé cardiovasculaire
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised...
Mené au Royaume-Uni sur 131 patients ayant survécu à un myélome multiple, cet essai de phase II évalue l’efficacité d’un programme d’exercices physiques pendant 6 mois pour réduire la fatigue et améliorer la force musculaire et la santé cardiovasculaire
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design
Dimitrios A. Koutoukidis, Joanne Land, Allan Hackshaw, Malgorzata Heinrich (et al.)
Background : Exercise may improve fatigue in multiple myeloma survivors, but trial evidence is limited, and exercise may be perceived as risky in this older patient group with osteolytic bone destruction. Methods : In this Phase 2 Zelen trial, multiple myeloma survivors who had completed treatment at least 6 weeks ago, or were on maintenance only, were enrolled in a cohort study and randomly assigned to usual care or a 6-month exercise programme of tailored aerobic and resistance training. [...]
Menée aux Etats-Unis à partir de données portant sur 1 617 patients atteints d’un cancer de la prostate, cette étude analyse l’effet de la maladie sur les fonctions urinaire et sexuelle et sur la gêne occasionnée, puis compare l’intérêt de ces deux critères (fonctions et gêne) dans l’évaluation de la qualité de vie
The relative impact of urinary and sexual function versus bother on health utility for men with prostate cancer
Menée aux Etats-Unis à partir de données portant sur 1 617 patients atteints d’un cancer de la prostate, cette étude analyse l’effet de la maladie sur les fonctions urinaire et sexuelle et sur la gêne occasionnée, puis compare l’intérêt de ces deux critères (fonctions et gêne) dans l’évaluation de la qualité de vie
The relative impact of urinary and sexual function versus bother on health utility for men with prostate cancer
Chang Wook Jeong, Annika Herlemann, Janet E Cowan (et al.)
Function and bother are related but distinct aspects of health-related quality of life (HRQoL). The objective of this study was to compare quantitatively the relative impacts of function and bother in urinary, sexual, and bowel outcomes on health utility as a reflection of HRQoL in men with prostate cancer. Our analysis included participants in the Cancer of the Prostate Strategic Urologic Research Endeavor utility supplementary study, with a final cohort of 1,617 men. Linear regression on the [...]
Mené au Royaume-Uni sur 130 patientes atteintes d’un cancer du sein, cet essai randomisé évalue l’efficacité d’une intervention de psychothérapie comportementale conduite par des infirmier(e)s pour réduire les bouffées de chaleur et les sueurs nocturnes et pour diminuer leurs effets sur la qualité de vie
Effectiveness of nurse-led group CBT for hot flushes and night sweats in women with breast cancer: results of the MENOS4 randomised controlled trial
Mené au Royaume-Uni sur 130 patientes atteintes d’un cancer du sein, cet essai randomisé évalue l’efficacité d’une intervention de psychothérapie comportementale conduite par des infirmier(e)s pour réduire les bouffées de chaleur et les sueurs nocturnes et pour diminuer leurs effets sur la qualité de vie
Effectiveness of nurse-led group CBT for hot flushes and night sweats in women with breast cancer: results of the MENOS4 randomised controlled trial
Deborah Fenlon, Tom Maishman, Laura Day (et al.)
Objective : Troublesome hot flushes and night sweats (HFNS) are experienced by many women after treatment for breast cancer, impacting significantly on sleep and quality of life. Cognitive behavioural therapy (CBT) is known to be effective for the alleviation of HFNS. However, it is not known if it can effectively be delivered by specialist nurses. We investigated whether group CBT delivered by breast care nurses (BCNs) can reduce the impact of HFNS. Methods : We recruited women with primary [...]
Menée en Australie auprès de 231 patientes atteintes d’un cancer du sein, cette étude analyse les effets d’une chirurgie mammaire reconstructrice sur les fonctions physiques et le niveau d'activité
Physical side-effects following breast reconstructive surgery impact physical activity and function
Menée en Australie auprès de 231 patientes atteintes d’un cancer du sein, cette étude analyse les effets d’une chirurgie mammaire reconstructrice sur les fonctions physiques et le niveau d'activité
Physical side-effects following breast reconstructive surgery impact physical activity and function
Deirdre E. McGhee, Julie R. Steele
Purpose : To investigate the incidence and severity of physical side-effects experienced by women following breast reconstructive surgery and the effect of these side-effects on physical activity and function. Methods : Two hundred and thirty-one Australian women (55 years SD 6.5) who had previously had breast reconstruction surgery retrospectively self-reported the incidence and severity of eight physical side-effects and the perceived effect of these side effects on six physical functions, at [...]
Mené sur 49 patients atteints un cancer de la tête et du cou, cet essai randomisé évalue l’efficacité d’un dispositif à compression pneumatique pour soulager eux-mêmes un lymphœdème associé à la maladie
Advanced pneumatic compression for treatment of lymphedema of the head and neck: a randomized wait-list controlled trial
Mené sur 49 patients atteints un cancer de la tête et du cou, cet essai randomisé évalue l’efficacité d’un dispositif à compression pneumatique pour soulager eux-mêmes un lymphœdème associé à la maladie
Advanced pneumatic compression for treatment of lymphedema of the head and neck: a randomized wait-list controlled trial
Sheila H. Ridner, Mary S. Dietrich, Jie Deng (et al.)
Purpose : Lymphedema associated with head and neck cancer (HNC) therapy causes adverse clinical outcomes. Standard treatment includes professionally administered complete decongestive therapy (CDT). Cost and availability of trained therapists are known barriers to therapy. Advanced pneumatic compression devices (APCD) may address these issues. A randomized, wait-list controlled trial was undertaken to evaluate an APCD in post-treatment HNC patients with lymphedema. Material and methods : [...]
Observation (9)
Menée aux Etats-Unis sur la période 1992-2011 par enquêtes auprès de 505 500 participants (âge : 18-103 ans), cette étude analyse le risque de décès lié aux comportements tabagiques, toutes causes confondues (47 000 décès) et par cancer
Dose-Response Association of Low-Intensity and Nondaily Smoking With Mortality in the United States
Menée aux Etats-Unis sur la période 1992-2011 par enquêtes auprès de 505 500 participants (âge : 18-103 ans), cette étude analyse le risque de décès lié aux comportements tabagiques, toutes causes confondues (47 000 décès) et par cancer
Dose-Response Association of Low-Intensity and Nondaily Smoking With Mortality in the United States
Inoue-Choi, Maki ; Christensen, Carol H. ; Rostron, Brian L. ; Cosgrove, Candace M. ; Reyes-Guzman, Carolyn ; Apelberg, Benjamin ; Freedman, Neal D.
An increasing proportion of US smokers smoke at low intensity and not every day. Some nondaily smokers have always had this pattern, whereas others previously smoked daily. The effect of reducing the level of smoking from daily to nondaily smoking and the dose response at low smoking levels are poorly understood.To evaluate risk of all-cause and cause-specific mortality among nondaily and daily cigarette smokers, by cigarettes per month, years after reducing from daily to nondaily smoking, and [...]
Menée aux Etats-Unis à partir de données portant sur 16 728 adolescents et jeunes adultes (âge : 15-39 ans) ayant survécu 5 ans à un cancer diagnostiqué entre 1970 et 2005, cette étude analyse les facteurs associés à l’évolution de la survie globale sur le long terme (durée médiane de suivi : 20 ans)
Long-term survival among 5-year survivors of adolescent and young adult cancer
Menée aux Etats-Unis à partir de données portant sur 16 728 adolescents et jeunes adultes (âge : 15-39 ans) ayant survécu 5 ans à un cancer diagnostiqué entre 1970 et 2005, cette étude analyse les facteurs associés à l’évolution de la survie globale sur le long terme (durée médiane de suivi : 20 ans)
Long-term survival among 5-year survivors of adolescent and young adult cancer
Amy M. Berkman, J. A. Livingston, Kelly Merriman PhD (et al.)
Background : Although there are a growing number of survivors of adolescent and young adult (AYA) cancer, to the authors' knowledge the long?term overall survival (OS) patterns for AYA cancer survivors are underreported. The objective of the current study was to assess the long?term survival of AYA cancer survivors and identify factors associated with diminished long?term survival. Methods : The authors used The University of Texas MD Anderson Cancer Center's tumor registry to identify 5?year [...]
Menée aux Etats-Unis auprès de 251 820 médecins généralistes et de 14 210 oncologues, cette étude analyse l’évolution, sur la période 2013-2017, de leurs pratiques de prescriptions d’opioïdes pour soulager la douleur chez des patients atteints d’un cancer et bénéficiant de la couverture Medicare
Changes in Opioid Prescribing Patterns Among Generalists and Oncologists for Medicare Part D Beneficiaries From 2013 to 2017
Menée aux Etats-Unis auprès de 251 820 médecins généralistes et de 14 210 oncologues, cette étude analyse l’évolution, sur la période 2013-2017, de leurs pratiques de prescriptions d’opioïdes pour soulager la douleur chez des patients atteints d’un cancer et bénéficiant de la couverture Medicare
Changes in Opioid Prescribing Patterns Among Generalists and Oncologists for Medicare Part D Beneficiaries From 2013 to 2017
Ankit Agarwal, Andrew Roberts, Stacie B. Dusetzina (et al.)
Importance : In response to the opioid epidemic, policies aiming to reduce opioid prescribing, misuse, and abuse may have the unintended consequence of restricting access to necessary opioid therapy for cancer-related pain. It is unknown how opioid prescribing patterns have changed among generalists and oncologists during this era. Objective : To examine trends in opioid prescription rates for Medicare Part D beneficiaries from 2013 to 2017 among oncologists and generalists. Design, Setting, [...]
Menée au Canada à partir de données portant sur 11 842 patients ayant survécu à un cancer pédiatrique et sur 59 210 témoins, cette étude analyse les facteurs associés au risque d’une perte d’audition significative et à l’utilisation d’un appareil auditif
Long-Term Incidence and Predictors of Significant Hearing Loss Requiring Hearing Assistive Devices Among Childhood Cancer Survivors: A Population-B...
Menée au Canada à partir de données portant sur 11 842 patients ayant survécu à un cancer pédiatrique et sur 59 210 témoins, cette étude analyse les facteurs associés au risque d’une perte d’audition significative et à l’utilisation d’un appareil auditif
Long-Term Incidence and Predictors of Significant Hearing Loss Requiring Hearing Assistive Devices Among Childhood Cancer Survivors: A Population-Based Study
Jason A. Beyea, Cindy Lau, Bonnie Cooke (et al.)
PURPOSE : Hearing loss is a significant late effect among childhood cancer survivors. Recent guidelines note insufficient evidence to quantify its natural history or risk associated with specific exposures. We examined the long-term incidence and predictors of hearing loss requiring hearing amplification devices (HADs) using population-based health care data. METHODS : In Ontario, Canada, HAD costs are subsidized by the Assistive Devices Program (ADP). Ontario children < 18 years of age at [...]
Menée aux Etats-Unis par enquête auprès de 635 539 participants entre 1987 et 2014, cette étude de cohorte analyse l’association entre une exposition aux particules fines, une pratique tabagique et la mortalité par cancer
Cancer mortality risk, fine particulate air pollution, and smoking in a large, representative cohort of US adults
Menée aux Etats-Unis par enquête auprès de 635 539 participants entre 1987 et 2014, cette étude de cohorte analyse l’association entre une exposition aux particules fines, une pratique tabagique et la mortalité par cancer
Cancer mortality risk, fine particulate air pollution, and smoking in a large, representative cohort of US adults
Nathan C. Coleman, Richard T. Burnett, Joshua D. Higbee (et al.)
Purpose : Air pollution and smoking are associated with various types of mortality, including cancer. The current study utilizes a publicly accessible, nationally representative cohort to explore relationships between fine particulate matter (PM2.5) exposure, smoking, and cancer mortality. Methods : National Health Interview Survey and mortality follow-up data were combined to create a study population of 635,539 individuals surveyed from 1987 to 2014. A sub-cohort of 341,665 never-smokers from [...]
Menée à partir d’une revue systématique de la littérature (68 essais), cette étude présente les recommandations pour la pratique clinique concernant la prophylaxie antifongique systémique chez les patients pédiatriques atteints d’un cancer et chez les patients ayant reçu une greffe de cellules souches hématopoïétiques
Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recip...
Menée à partir d’une revue systématique de la littérature (68 essais), cette étude présente les recommandations pour la pratique clinique concernant la prophylaxie antifongique systémique chez les patients pédiatriques atteints d’un cancer et chez les patients ayant reçu une greffe de cellules souches hématopoïétiques
Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients
Thomas Lehrnbecher, Brian T. Fisher, Bob Phillips (et al.)
PURPOSE : To develop a clinical practice guideline for systemic antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation (HSCT) recipients. METHODS : Recommendations were developed by an international multidisciplinary panel that included a patient advocate. We conducted a systematic review of systemic antifungal prophylaxis in children and adults with cancer and HSCT recipients. The Grading of Recommendations Assessment, Development, and Evaluation [...]
Menée en Allemagne à partir de données portant sur 815 patients atteints d’un myélome multiple, cette étude analyse les facteurs associés à la survie conditionnelle à 5 ans
Risk of disease recurrence and survival in patients with multiple myeloma: A German study group analysis using a conditional survival approach with...
Menée en Allemagne à partir de données portant sur 815 patients atteints d’un myélome multiple, cette étude analyse les facteurs associés à la survie conditionnelle à 5 ans
Risk of disease recurrence and survival in patients with multiple myeloma: A German study group analysis using a conditional survival approach with long-term follow-up of 815 patients
Maximilian Schinke, Gabriele Ihorst, Justus Duyster (et al.)
Background : Unlike the traditional method of overall survival prediction in patients with cancer, conditional survival predicts the survival of patients dynamically throughout the course of disease, identifying how a prognosis evolves over time. Methods : The authors assessed 815 consecutive patients with multiple myeloma through the German Study Group on Multiple Myeloma (Deutsche Studiengruppe Multiples Myelom; DSMM) incentive. Over 10 variables, including patient?specific and multiple [...]
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cancer and COVID-19: unmasking their ties
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cancer and COVID-19: unmasking their ties
A. Addeo, A. Friedlaender
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and its clinical manifestation, the coronavirus disease 2019 (COVID19) have rapidly spread across the globe, leading to the declaration of a pandemic. While most present mild symptoms, it appears as though nearly 20% of confirmed patients develop significant complications. These include acute respiratory distress syndrome, septic shock and multi-organ failure, with a 3-6% mortality. A plethora of treatments has been or is being [...]
Developing a risk assessment score for cancer patients during COVID-19 pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Developing a risk assessment score for cancer patients during COVID-19 pandemic
Alice Indini, Erika Rijavec, Michele Ghidini (et al.)
The novel coronavirus (CoV) pandemic is a serious threat for cancer patients, who have an immunocompromised status, and are considered at high risk for infections. Data on the novel CoV respiratory disease (COVID-19) in cancer patients are still limited. Unlike other common viruses, CoV have not shown to cause a more severe disease in immunocompromised subjects. Along with direct viral pathogenicity, in some individuals CoV infection triggers an uncontrolled aberrant inflammatory response, [...]
Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19
Daniel A. Goldstein, Mark J. Ratain, Leonard B. Saltz
The coronavirus disease 2019 (COVID-19) pandemic has shocked the world and caused a period of both economic and medical catastrophe. Two major challenges face the world of medical oncology. Oncologists need to reconsider all of their clinical practices to decrease the risk of exposure of their patients to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Oncologists also need to consider that the world has changed considerably in economic terms. Now, more than ever, we need to [...]
Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic
Eric C. Ip, Shing Fung Lee
The continuing outbreak of the coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2 has inflicted considerable burdens onto the health system of China, the world's most populous country. Remarkably, among spectrum of potential mitigation strategies, the Chinese government has implemented all-out lockdowns on large geographical areas, unprecedented in the modern era. This inevitably undermined the right to healthcare of many who now faced great difficulty in getting [...]
Providing nutritional care to cancer patients during the COVID-19 pandemic: an Italian perspective
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Providing nutritional care to cancer patients during the COVID-19 pandemic: an Italian perspective
Federica Lobascio, Riccardo Caccialanza, Teresa Monaco, Emanuele Cereda, Simona Secondino, Sara Masi, Silvia Crotti, Gianpiero Rizzo, Silvia Cappello, Valeria Borioli, Marco Inglardi, Giuseppina Grugnetti, Alba Muzzi, Antonio Triarico, Paolo Pedrazzoli & Silvia Brugnatelli
The COVID-19 outbreak has drastically changed practices inside hospitals, which include oncology routines. In oncology, malnutrition was and certainly still is a frequent problem associated with an increase in treatment-related toxicity, a reduced response to cancer treatment, an impaired quality of life, and a worse overall prognosis. Even in this situation of healthcare crisis, nutritional support in cancer care is an essential element. During the current COVID-19 pandemic, there is a [...]
Screening for COVID-19 in Asymptomatic Patients With Cancer in a Hospital in the United Arab Emirates
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Screening for COVID-19 in Asymptomatic Patients With Cancer in a Hospital in the United Arab Emirates
Humaid O. Al-Shamsi, Eric A. Coomes, Sadir Alrawi (et al.)
As the coronavirus disease 2019 (COVID-19) pandemic grows, accumulating evidence suggests that patients with cancer have increased risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and subsequent morbidity and mortality.1-3 Further, COVID-19 may be asymptomatic.4 Despite limited evidence, the European Society for Medical Oncology recommends universal microbiologic SARS-CoV-2 screening for patients undergoing active anticancer therapy.5 To identify asymptomatic [...]
Covid-19 and lung cancer: A greater fatality rate?
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Covid-19 and lung cancer: A greater fatality rate?
Jacobo Rogado, Cristina Pangua, Gloria Serrano-Montero
Background : Currently there are no reported series determining the Covid-19 infected lung cancer patient´s characteristics and outcome that allow us to clarify strategies to protect our patients. In our study we determine whether exists differences in cumulative incidence and severity of Covid-19 infection between lung cancer patients visiting our Medical Oncology department and the reference population of our center (320,000 people), in the current epicenter of the pandemic in Europe (Madrid, [...]
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrosp...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
Jianbo Tian, Prof Xianglin Yuan, Jun Xiao (et al.)
Background : COVID-19 has spread globally. Epidemiological susceptibility to COVID-19 has been reported in patients with cancer. We aimed to systematically characterise clinical features and determine risk factors of COVID-19 disease severity for patients with cancer and COVID-19. Methods : In this multicentre, retrospective, cohort study, we included all adult patients (aged ?18 years) with any type of malignant solid tumours and haematological malignancy who were admitted to nine hospitals in [...]
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials
Joseph M. Unger, Charles D. Blanke, Michael LeBlanc (et al.)
Introduction : Enrollment in clinical trials is key in advancing new treatments for patients with cancer. Poor accrual can result in trials that fail to complete or generate less timely research findings for patients in need of better therapies. The outbreak of coronavirus disease 2019 (COVID-19) has caused severe disruptions in care for many patients—especially patients with cancer, who are more susceptible to infections because of underlying malignant neoplasms or therapy—in an effort to [...]
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Lennard Y W Lee, Prof Jean Baptiste Cazier, T Starkey (et al.)
Background : Individuals with cancer, particularly those who are receiving systemic anticancer treatments, have been postulated to be at increased risk of mortality from COVID-19. This conjecture has considerable effect on the treatment of patients with cancer and data from large, multicentre studies to support this assumption are scarce because of the contingencies of the pandemic. We aimed to describe the clinical and demographic characteristics and COVID-19 outcomes in patients with cancer. [...]
Poor clinical outcomes for patients with cancer during the COVID-19 pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Poor clinical outcomes for patients with cancer during the COVID-19 pandemic
Liang V Tang, Yu Hu
According to global cancer statistics, there were an estimated 18·1 million new cancer cases and 9·6 million cancer deaths worldwide in 2018. In the ongoing COVID-19 pandemic, these millions of patients with cancer seem to be more susceptible to the viral disease than the general population. Indeed, they could be more likely to develop severe complications of COVID-19, owing to their immunosuppressed status caused by both the cancer and anticancer therapies, such as radiotherapy, chemotherapy, [...]
The starting line for COVID-19 vaccine development
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The starting line for COVID-19 vaccine development
Nelson Lee, Allison McGeer
Developing a safe and effective COVID-19 vaccine is a global priority to end this pandemic. In their dose-escalation, single-centre, open-label, phase 1 trial published in The Lancet, Feng-Cai Zhu and colleagues1 report the safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine, which expresses the full length spike glycoprotein of the Wuhan-Hu-1 strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 108 healthy adults who [...]
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah (et al.)
Background : Data on patients with COVID-19 who have cancer are lacking. Here we characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify potential prognostic factors for mortality and severe illness. Methods : In this cohort study, we collected de-identified data on patients with active or previous malignancy, aged 18 years and older, with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection from the USA, Canada, and Spain from the [...]
Cancer treatment during COVID-19 pandemic: do not postpone but decide wisely
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cancer treatment during COVID-19 pandemic: do not postpone but decide wisely
Olivier Huillard, Francois Goldwasser
We thank Omarini et al. for sharing the practical health recommendations adopted in their center and their experience with COVID-19. They conclude that cancer care cannot be postponed only on the basis of the risk of COVID-19 infection. Even if we agree on the general principle that cancer treatment cannot be definitively postponed in the context of a pandemic which end is uncertain, we believe that decisions may differ from those made in the pre COVID-19 context (…)
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospecti...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
Prof Kunyu Yang, Yuhan Sheng, Prof Chaolin Huang (et al.)
Background : Patients with cancer are a high-risk population in the COVID-19 pandemic. We aimed to describe clinical characteristics and outcomes of patients with cancer and COVID-19, and examined risk factors for mortality in this population. Methods : We did a retrospective, multicentre, cohort study of 205 patients with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and with a pathological diagnosis of a malignant tumour in nine hospitals within [...]
Weathering the Storm: Managing Older Adults with Breast Cancer Amid COVID-19 and Beyond
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Weathering the Storm: Managing Older Adults with Breast Cancer Amid COVID-19 and Beyond
Rachel A Freedman, Mina S Sedrak, Jennifer R Bellon (et al.)
Caring for older patients with breast cancer presents unique clinical considerations due to preexisting and competing comorbidity, the potential for treatment-related toxicity, and the consequent impact on functional status. In the context of the COVID-19 pandemic, treatment decision-making for older patients is especially challenging and encourages us to re-focus our treatment priorities. While we work to avoid treatment delays and maintain therapeutic benefit, we also need to minimize the [...]
Immune checkpoint inhibitors: A physiology-driven approach to the treatment of COVID-19
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Immune checkpoint inhibitors: A physiology-driven approach to the treatment of COVID-19
Serena Di Cosimo, Andrea Malfettone, José Manuel Pérez-García (et al.)
While confirmed cases of infections of the deadly coronavirus disease 2019 (COVID-19) have exceeded 4.7 million globally, scientists are pushing forward with efforts to develop vaccines and treatments in an attempt to slow the pandemic and lessen the disease’s damage. Although no proven effective therapies to treat COVID-19 patients or for managing their complications currently exist, the rapidly expanding knowledge regarding severe acute respiratory syndrome–coronavirus 2 and its interplay [...]
Working in the dark: Interaction with a sub clinical COVID-19 subject and lessons learned
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Working in the dark: Interaction with a sub clinical COVID-19 subject and lessons learned
Shrinivas Rathod, Shahida Ahmed, Robin Vanstone (et al.)
Protecting health-care workers from subclinical coronavirus infection is a challenge. We present a clinical interaction with a breast cancer patient with subclinical COVID-19 and the lessons we learned from this interaction.
Treating the SARS-CoV-2–positive patient with cancer: A proposal for a pragmatic and transparent ethical process
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Treating the SARS-CoV-2–positive patient with cancer: A proposal for a pragmatic and transparent ethical process
Subha Perni, Michael G. Milligan, MBA Anurag Saraf, Todd Vivenzio(et al.)
The treatment of patients with cancer who test positive for severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2) poses unique challenges. In this commentary, the authors describe the ethical rationale and implementation details for the creation of a novel, multidisciplinary treatment prioritization committee, including physicians, frontline staff, an ethicist, and an infectious disease expert. Organizational obligations to health care workers also are discussed. The treatment [...]
Menée en Angleterre à partir de données portant sur 5 024 patientes atteintes d’un carcinome canalaire in situ diagnostiqué entre 1988 et 2014 dans le cadre du programme de dépistage, cette étude de cohorte analyse les facteurs associés au risque de développer un cancer invasif du sein ainsi qu’au risque de décès par cancer du sein
Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: po...
Menée en Angleterre à partir de données portant sur 5 024 patientes atteintes d’un carcinome canalaire in situ diagnostiqué entre 1988 et 2014 dans le cadre du programme de dépistage, cette étude de cohorte analyse les facteurs associés au risque de développer un cancer invasif du sein ainsi qu’au risque de décès par cancer du sein
Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study
Gurdeep S Mannu, Zhe Wang, John Broggio, Jackie Charman (et al.)
Objective To evaluate the long term risks of invasive breast cancer and death from breast cancer after ductal carcinoma in situ (DCIS) diagnosed through breast screening. Design Population based observational cohort study. Setting Data from the NHS Breast Screening Programme and the National Cancer Registration and Analysis Service. Participants All 35 024 women in England diagnosed as having DCIS by the NHS Breast Screening Programme from its start in 1988 until March 2014. Main outcome [...]
Approches psycho-sociales (1)
A partir d’une revue de la littérature (9 études, 446 patients), cette méta-analyse évalue les effets de l’art-thérapie sur les symptômes d’anxiété et de dépression chez des patientes atteintes d’un cancer du sein
The effects of art therapy on anxiety and depression in breast cancer patients: An updated meta-analysis
A partir d’une revue de la littérature (9 études, 446 patients), cette méta-analyse évalue les effets de l’art-thérapie sur les symptômes d’anxiété et de dépression chez des patientes atteintes d’un cancer du sein
The effects of art therapy on anxiety and depression in breast cancer patients: An updated meta-analysis
Linlin Xu, Pengfei Cheng, Yu Wu, Junxiang Zhang, Jiaying Zhu (et al.)
Objective : In this meta?analysis, we aimed to investigate the effects of art therapy on anxiety and depression in patients with breast cancer. Methods : Electronic databases were searched for relevant studies through December 2019. Standardised mean differences (SMDs) were calculated as the effects of art therapy on improvement of anxiety and depression in women with breast cancer. The meta?analysis included nine studies involving a total of 446 participants. Results : The summary SMD of art [...]
Analyses économiques et systèmes de soins (2)
Menée aux Etats-Unis, cette étude analyse les disparités ethniques dans les années potentielles de vies perdues et dans les pertes de revenus liées aux décès prématurés par cancer en 2015
Racial/Ethnic Disparities in Lost Earnings from Cancer Deaths in the United States
Menée aux Etats-Unis, cette étude analyse les disparités ethniques dans les années potentielles de vies perdues et dans les pertes de revenus liées aux décès prématurés par cancer en 2015
Racial/Ethnic Disparities in Lost Earnings from Cancer Deaths in the United States
Jingxuan Zhao, Kimberly D Miller, Farhad Islami (et al.)
Background : Little is known about disparities in economic burden due to premature cancer deaths by race/ethnicity in the United States. This study aimed to compare person-years of life lost (PYLL) and lost earnings due to premature cancer deaths by race/ethnicity. Methods : PYLL was calculated using recent national cancer death and life expectancy data. PYLL was combined with annual median earnings to generate lost earnings. We compared PYLL and lost earnings among individuals who died at age [...]
Menée dans un contexte américain, cette étude analyse le rapport coût-efficacité d’un traitement de consolidation par durvalumab après une chimioradiothérapie chez des patients atteints d’un cancer du poumon non à petites cellules de stade III
Durvalumab vs placebo consolidation therapy after chemoradiotherapy in stage III non-small-cell lung cancer: An updated PACIFIC trial-based cost-ef...
Menée dans un contexte américain, cette étude analyse le rapport coût-efficacité d’un traitement de consolidation par durvalumab après une chimioradiothérapie chez des patients atteints d’un cancer du poumon non à petites cellules de stade III
Durvalumab vs placebo consolidation therapy after chemoradiotherapy in stage III non-small-cell lung cancer: An updated PACIFIC trial-based cost-effectiveness analysis
Jiaqi Hana, Kun Tianb, Jiangping Yanga, Youling Gong (et al.)
Introduction : Recently updated three-year survival data from the PACIFIC trial showed that durvalumab consolidation therapy improved OS rates versus placebo for patients with unresectable stage III non-small cell lung cancer (NSCLC) after chemoradiotherapy. Considering the impact of the high cost of durvalumab, its cost-effectiveness should be updated to see if its cost-effectiveness has changed from the US payers’ perspective. Methods : A comprehensive Markov model was used to evaluate mean [...]
Sensibilisation et communication (1)
A partir d’une revue de la littérature (7 études), cette étude analyse l’efficacité des interventions pédagogiques destinées aux oncologues pour améliorer leurs connaissances concernant la qualité de la vie sexuelle des patients atteints d’un cancer
Can the provision of sexual healthcare for oncology patients be improved? A literature review of educational interventions for healthcare professio...
A partir d’une revue de la littérature (7 études), cette étude analyse l’efficacité des interventions pédagogiques destinées aux oncologues pour améliorer leurs connaissances concernant la qualité de la vie sexuelle des patients atteints d’un cancer
Can the provision of sexual healthcare for oncology patients be improved? A literature review of educational interventions for healthcare professionals
L.F. Albers, L.A. Grondhuis Palacios, R.C.M. Pelger (et al.)
Purpose : Sexual health is an important quality-of-life concern for cancer patients and survivors, but a difficult discussion topic for patients and healthcare professionals. The most important barriers causing healthcare professionals to avoid the topic are lack of education and lack of knowledge. How effective education about sexual health is for oncology healthcare professionals is not clear. The aim of this review is to examine the effectiveness of interventions in improving the provision [...]
Soins palliatifs (2)
Mené aux Etats-Unis sur 68 patients atteints d’un cancer de stade avancé, souffrant d’un délire et pris en charge dans des unités de soins palliatifs, cet essai randomisé analyse les effets, sur la réduction de l’agitation terminale du patient, de 3 stratégies d’utilisation de neuroleptiques
Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind,...
Mené aux Etats-Unis sur 68 patients atteints d’un cancer de stade avancé, souffrant d’un délire et pris en charge dans des unités de soins palliatifs, cet essai randomisé analyse les effets, sur la réduction de l’agitation terminale du patient, de 3 stratégies d’utilisation de neuroleptiques
Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial
David Hui, Allison De La Rosa, Annie Wilson (et al.)
Background : The role of neuroleptics for terminal agitated delirium is controversial. We assessed the effect of three neuroleptic strategies on refractory agitation in patients with cancer with terminal delirium. Methods : In this single-centre, double-blind, parallel-group, randomised trial, patients with advanced cancer, aged at least 18 years, admitted to the palliative and supportive care unit at the University of Texas MD Anderson Cancer Center (Houston, TX, USA), with refractory [...]
Optimal goal of management of delirium in end-of-life cancer care
Mené aux Etats-Unis sur 68 patients atteints d’un cancer de stade avancé, souffrant d’un délire et pris en charge dans des unités de soins palliatifs, cet essai randomisé analyse les effets, sur la réduction de l’agitation terminale du patient, de 3 stratégies d’utilisation de neuroleptiques
Optimal goal of management of delirium in end-of-life cancer care
Tatsuo Akechi
Delirium is a highly prevalent neuropsychiatric problem in patients with advanced cancer. Delirium that develops in the last days and hours of life is not only very common, but also distressing both for patients and their families; therefore, appropriate management of terminal delirium is essential. Among the various symptoms of delirium, persistent agitation or restlessness, are considered to cause the most distress to patients. Although sufficient relief from distressing symptoms is [...]
Menée à partir des données des registres américains portant sur des patients atteints d’un cancer métastatique du poumon diagnostiqué sur la période 2001-2015, cette étude analyse les disparités géographiques dans l’utilisation des soins palliatifs
Geographic variation in palliative care delivery among patients diagnosed with metastatic lung cancer in the USA: Medicare population-based study
Menée à partir des données des registres américains portant sur des patients atteints d’un cancer métastatique du poumon diagnostiqué sur la période 2001-2015, cette étude analyse les disparités géographiques dans l’utilisation des soins palliatifs
Geographic variation in palliative care delivery among patients diagnosed with metastatic lung cancer in the USA: Medicare population-based study
Jinhai Huo, Young-Rock Hong, Kea Turner, Cheng Chen, Yi Guo (et al.)
Purpose : The USA has observed a significant increase in the use of palliative care for patients diagnosed with advanced cancer. However, it is unknown how geographic variation affects patients’ use of palliative care services. We examined temporal and demographic trends in receipt of and timing of palliative care by state and region. Methods : A retrospective cohort study of the Surveillance, Epidemiology, and End Results (SEER)-Medicare database. Study sample included community-dwelling [...]
Médecines parallèles (1)
Menée en France par enquête en 2015-2016 auprès de 4 174 patients ayant survécu 5 ans à un cancer, cette étude analyse leur utilisation de médecines non conventionnelles et l’impact de celles-ci sur la qualité de vie et sur les comportements de santé
Use of non-conventional medicine and lifestyle change among cancer survivors: evidence from the national VICAN survey
Menée en France par enquête en 2015-2016 auprès de 4 174 patients ayant survécu 5 ans à un cancer, cette étude analyse leur utilisation de médecines non conventionnelles et l’impact de celles-ci sur la qualité de vie et sur les comportements de santé
Use of non-conventional medicine and lifestyle change among cancer survivors: evidence from the national VICAN survey
Aline Sarradon-Eck, Dominique Rey, Rajae Touzani (et al.)
Purpose : This study aimed to investigate the use of non-conventional medicine (NCM) among long-term cancer survivors and its links with healthy behavior. Methods : This study used data from the VICAN survey, conducted in 2015–2016 on a representative sample of French cancer survivors 5 years after diagnosis. Results : Among the 4174 participants, 21.4% reported using NCM at the time of the survey, including 8.4% who reported uses not associated with cancer. The most frequently cited reasons [...]
Ressources et infrastructures (Lutte contre les cancers) (1)
Cette étude souligne l’importance, au niveau mondial, de l’enregistrement des données concernant les cancers de l’enfant pour disposer des données de survie de qualité, notamment dans les pays les moins développés économiquement
Scaling up the surveillance of childhood cancer: a global roadmap
Cette étude souligne l’importance, au niveau mondial, de l’enregistrement des données concernant les cancers de l’enfant pour disposer des données de survie de qualité, notamment dans les pays les moins développés économiquement
Scaling up the surveillance of childhood cancer: a global roadmap
Marion Piñeros, Les Mery, Isabelle Soerjomataram (et al.)
The World Health Organization recently launched the Global Initiative for Childhood Cancer (GICC) aiming to substantially increase survival among children with cancer by 2030. The ultimate goal concerns particularly less developed countries where survival estimates are considerably lower than in high-income countries where children with cancer attain approximately 80% survival. Given the vast gap in high-quality data availability between more and less developed countries, measuring the success [...]